# A Randomized Double Blind Study Evaluating Duloxetine in Outpatients With MDD and Pain

> **NCT00191919** · PHASE3 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 310 (—)

## Conditions studied

- Depressive Disorder, Major

## Interventions

- **DRUG:** Duloxetine Hydrochloride
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00191919
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-05
- **Primary completion:** —
- **Final completion:** 2006-05
- **Target enrollment:** 310 (—)
- **Last updated:** 2007-01-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00191919

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00191919, "A Randomized Double Blind Study Evaluating Duloxetine in Outpatients With MDD and Pain". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT00191919. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*